"Wegovy: The Weight-Loss Wonder Drug in High Demand"

Wegovy, a weight-loss drug containing semaglutide, has seen a surge in sales and popularity, with its manufacturer Novo Nordisk becoming Europe's most valuable listed company. Despite its effectiveness in helping severely overweight individuals lose weight, there are concerns about side effects, cost, and long-term efficacy. The success of Wegovy has led to a competitive market for weight-loss drugs, with other pharmaceutical companies racing to develop similar products.